The phrase "address the predictive value" is correct and usable in written English.
You can use it when discussing the importance or significance of predictive value in a statistical or analytical context.
Example: "In our study, we need to address the predictive value of the new model to determine its effectiveness in forecasting outcomes."
Alternatives: "consider the predictive value" or "evaluate the predictive value".
We will in future studies address the predictive value of laboratory investigation in childhood arteriopathies.
They suggested a need to address the predictive value of these predictors in the context of biomarker studies.
First, we want to address the predictive value of labour pain acceptance and personal control in pain relief for the use of pain medication during childbirth (See RQ1).
We are currently planning to establish a staining of our three biomarkers in patient kidney biopsy samples in order to prospectively address the predictive value of this biomarker.
Much larger studies will be needed to address the predictive value of PIK3CA mutations in different molecular subsets of breast cancer in the context of different chemotherapies.
First, some studies do have addressed the predictive value of patients with metabolically nonresponding liver metastases after treatment for OS and EFS.
The relation we found between smoking and levels of FGF23 is in line with a recent study that addressed the predictive value of FGF23 on death and progression to end stage kidney disease [ 23].
However, none of these studies formally addressed the predictive value of any of the EEG findings during TH or compared the value of EEG with that of neurologic examination or SSEPs, the latter being regarded as reliable predictors of poor prognosis [ 5].
Our study addressed (a) how the predictive value of dementia risk varies by the number of deficits considered and (b) how traditional (for example. vascular risks) and nontraditional risk factors (for example, foot problems, nasal congestion) compare in their predictive effects.
To date we lack evidence supporting the use of denosumab in patients with primary breast cancer, yet several studies are currently ongoing to address this question including the predictive value of RANKL expression [ 25].
